Advertisement
Abstract| Volume 331, e129, August 2021

Cholesterol efflux capacity is associated with inflammation level and monocyte-platelet aggregates in healthy men.

      Background and Aims: It is well established that HDL particles have antiatherogenic properties. However, there are conflicting evidence in regards to HDL particle function and its association with various CVD risk factors. The aim of our study was to analyze associations between the marker of HDL function - cholesterol efflux capacity (CEC) and traditional (age, serum lipids, CRP) and emerging (monocyte-platelet aggregates (MPAs)) CVD risk markers.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect